These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Options in dialysis therapy: significance of cardiovascular findings. Wizemann V; Timio M; Alpert MA; Kramer W Kidney Int Suppl; 1993 Feb; 40():S85-91. PubMed ID: 8445844 [TBL] [Abstract][Full Text] [Related]
5. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients? Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917 [TBL] [Abstract][Full Text] [Related]
6. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy and blood pressure control in automated and continuous ambulatory peritoneal dialysis patients. Ataş N; Erten Y; Okyay GU; Inal S; Topal S; Öneç K; Akyel A; Çelik B; Tavil Y; Bali M; Arınsoy T Ther Apher Dial; 2014 Jun; 18(3):297-304. PubMed ID: 24965296 [TBL] [Abstract][Full Text] [Related]
8. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Stack AG; Saran R Am J Kidney Dis; 2002 Dec; 40(6):1202-10. PubMed ID: 12460039 [TBL] [Abstract][Full Text] [Related]
9. Hemodialysis versus continuous ambulatory peritoneal dialysis: effects on the heart. Canziani ME; Cendoroglo Neto M; Saragoça MA; Cassiolato JL; Ramos OL; Ajzen H; Draibe SA Artif Organs; 1995 Mar; 19(3):241-4. PubMed ID: 7779013 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens. Wang MC; Tseng CC; Tsai WC; Huang JJ Perit Dial Int; 2001; 21(1):36-42. PubMed ID: 11280494 [TBL] [Abstract][Full Text] [Related]
12. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients. Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor-23 and interleukin-6 are risk factors for left ventricular hypertrophy in peritoneal dialysis patients. Liu WH; Zhou QL; Ao X; Yu HL; Peng WS; He N J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):565-9. PubMed ID: 22728833 [TBL] [Abstract][Full Text] [Related]
14. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients. Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412 [TBL] [Abstract][Full Text] [Related]
15. An echocardiographic assessment of cardiac functions and structure in children on dialysis. Haciomeroglu P; Ozkaya O; Gunal N; Baysal K Ren Fail; 2008; 30(2):147-53. PubMed ID: 18300113 [TBL] [Abstract][Full Text] [Related]
16. Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients. Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kimura G Ren Fail; 2002 Mar; 24(2):175-86. PubMed ID: 12071591 [TBL] [Abstract][Full Text] [Related]
18. Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses. Mimura I; Nishi H; Mise N; Mori M; Sugimoto T Nephrology (Carlton); 2010 Aug; 15(5):549-54. PubMed ID: 20649875 [TBL] [Abstract][Full Text] [Related]
19. Continuous ambulatory peritoneal dialysis in high-risk patients: patients with cardiovascular diseases--role of the nurse. Lambert MC; Schilling H Perit Dial Int; 1999; 19 Suppl 2():S499-504. PubMed ID: 10406572 [TBL] [Abstract][Full Text] [Related]
20. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients. Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]